Halagon 0.5mg/ml

Oral solution for calves

Composition

Halofuginone (as lactate salt): 0.50 mg eq. to 0.6086 mg of halofuginone lactate.

Pharmacotherapeutic category

Antiprotozoal agents.

Pharmacotherapeutic category

The active substance, halofuginone, is an antiprotozoal agent of the quinazolinone derivatives group (nitrogenous polyheterocycles). Halofuginone lactate is a salt whose antiprotozoal properties and efficacy against Cryptosporidium parvum have been demonstrated both in in vitro conditions and in artificial and natural infections. The compound has a cryptosporidiostatic effect on Cryptosporidium parvum. It is mainly active on the free stages of the parasite (sporozoïte, merozoïte). The concentrations to inhibit 50% and 90% of the parasites, in an in vitro test system, are IC50 < 0.1 μg/ml and IC90 of 4.5 μg/ml, respectively.

Indications

In newborn calves:

  • Prevention of diarrhoea due to diagnosed Cryptosporidium parvum infection, in farms with history of cryptosporidiosis.
  • Reduction of diarrhoea due to diagnosed Cryptosporidium parvum infection.

Dosage, route and method of administration

Administration after feeding: 100 μg of halofuginone / kg bw / once a day for 7 consecutive days, i.e. 4 ml of HALAGON / 20 kg bw / once a day for 7 consecutive days.

Shelf-life

2 years.

Packaging

Cardboard box containing one bottle (high-density polyethylene) of 290 ml, 490 ml or 980 ml.


Guidance document for correct use of the dosing device: download pdf.

Guidance video for correct use of the dosing device:




The trade name and/or the specifications of the product (target animal species, indications, dosage and administration, precautions and warnings, etc.) may differ from country to country. Please contact us for further information.

Website by www.digimade.be